Research Archive — Page 46 of 131
-
January 6, 2023
Early effects of Huntington disease
Impairments in brain executive function happen earlier than motor symptoms in people with the gene mutation that causes Huntington disease, suggesting younger ages and cognitive symptoms be considered for any future clinical trials. -
January 6, 2023
MicroRNAs linked to lipid damage
VUMC researchers have linked microRNAs with systemic lipid peroxidation, a discovery that could point to new therapeutic targets for a variety of diseases. -
January 5, 2023
VUMC researchers upend dogma about vasopressin production
Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney. -
December 28, 2022
Vanderbilt mourns loss of renowned scientist Exton
John H. Exton, MBChB, MD, PhD, professor of Molecular Physiology and Biophysics, emeritus at Vanderbilt University, whose research provided fundamental insights into how many biologically active compounds control cellular physiology, died Dec. 18. He was 89. -
December 16, 2022
VUMC Announces VICTR Leadership Transition
-
December 15, 2022
Novel therapeutic target identified for chronic kidney disease
Vanderbilt investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury. -
December 15, 2022
Reduced kidney function may cause cardiovascular disease: study
An international team of investigators has found that mild to moderate reduction in kidney function may cause cardiovascular disease, even in people without symptoms of heart disease or diabetes.